NO20072587L - Fenyldiazepankarboksamider og anilerte fenylpiperazinkarboksamider inneholdende oksygen og benyttet som dopamin D3 antagonister - Google Patents
Fenyldiazepankarboksamider og anilerte fenylpiperazinkarboksamider inneholdende oksygen og benyttet som dopamin D3 antagonisterInfo
- Publication number
- NO20072587L NO20072587L NO20072587A NO20072587A NO20072587L NO 20072587 L NO20072587 L NO 20072587L NO 20072587 A NO20072587 A NO 20072587A NO 20072587 A NO20072587 A NO 20072587A NO 20072587 L NO20072587 L NO 20072587L
- Authority
- NO
- Norway
- Prior art keywords
- phenylpiperazine
- containing oxygen
- phenyldiazepanecarboxamides
- anylated
- dopamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Addiction (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004063797A DE102004063797A1 (de) | 2004-12-30 | 2004-12-30 | Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide |
PCT/EP2005/014047 WO2006072430A1 (de) | 2004-12-30 | 2005-12-27 | Sauerstoffhaltige annelierte phenylpiperazin- und phenyldiazepancarboxamide als dopamin d3 antagonisten |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072587L true NO20072587L (no) | 2007-05-21 |
Family
ID=36102609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072587A NO20072587L (no) | 2004-12-30 | 2007-05-21 | Fenyldiazepankarboksamider og anilerte fenylpiperazinkarboksamider inneholdende oksygen og benyttet som dopamin D3 antagonister |
Country Status (22)
Country | Link |
---|---|
US (1) | US20080194539A1 (sl) |
EP (1) | EP1761524B1 (sl) |
JP (1) | JP2008526700A (sl) |
KR (1) | KR20070102673A (sl) |
CN (1) | CN101027294A (sl) |
AU (1) | AU2005324107A1 (sl) |
BR (1) | BRPI0519485A2 (sl) |
CA (1) | CA2576332A1 (sl) |
DE (2) | DE102004063797A1 (sl) |
DK (1) | DK1761524T3 (sl) |
EA (1) | EA200701366A1 (sl) |
ES (1) | ES2297767T3 (sl) |
HK (1) | HK1100845A1 (sl) |
HR (1) | HRP20080075T3 (sl) |
IL (1) | IL180763A0 (sl) |
MX (1) | MX2007006369A (sl) |
NO (1) | NO20072587L (sl) |
PL (1) | PL1761524T3 (sl) |
PT (1) | PT1761524E (sl) |
SI (1) | SI1761524T1 (sl) |
WO (1) | WO2006072430A1 (sl) |
ZA (1) | ZA200701972B (sl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5701213B2 (ja) * | 2008-10-10 | 2015-04-15 | インスティチュート オブ ファーマコロジー アンド トキシコロジー アカデミー オブ ミリタリー メディカル サイエンシズ ピー.エル.エー.チャイナ | 新規なドーパミンd3受容体リガンド、その調製及び使用 |
US9227944B2 (en) | 2008-10-10 | 2016-01-05 | Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China | Dopamine D3 receptor ligands and preparation and medical uses of the same |
CA2754904A1 (en) * | 2009-03-10 | 2010-09-16 | Takeda Pharmaceutical Company Limited | Benzofuran derivatives |
CN103282369A (zh) * | 2011-04-08 | 2013-09-04 | 劳乐斯实验室私营有限公司 | 抗逆转录病毒化合物与抗氧化酸的固体形式、其制备方法以及其药物组合物 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL90279A (en) * | 1988-05-24 | 1995-03-30 | American Home Prod | History of piperazinyl carboxamide, their preparation and the pharmaceutical preparations containing them |
NZ231631A (en) * | 1988-12-08 | 1992-07-28 | Duphar Int Res | Heterocyclically-substituted piperazine and diazepine derivatives and anxiolytic compositions |
DE4127849A1 (de) * | 1991-08-22 | 1993-02-25 | Merck Patent Gmbh | Benzodioxanderivate |
DE4333254A1 (de) * | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
CA2297825C (en) * | 1997-07-25 | 2006-03-14 | H. Lundbeck A/S | Indole and 2,3-dihydroindole derivatives, their preparation and use |
FR2781671A1 (fr) * | 1998-07-28 | 2000-02-04 | Synthelabo | Compositions pharmaceutiques contenant un inhibiteur de la recapture de la serotonine et leur application en therapeutique |
AR022303A1 (es) * | 1999-01-22 | 2002-09-04 | Lundbeck & Co As H | Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion |
GB9905010D0 (en) * | 1999-03-04 | 1999-04-28 | Merck Sharp & Dohme | Therapeutic agents |
ES2188344B1 (es) * | 2000-11-29 | 2004-09-16 | Laboratorios Vita, S.A. | Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos. |
HUP0103987A3 (en) * | 2001-09-28 | 2004-11-29 | Richter Gedeon Vegyeszet | Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates |
MXPA05000033A (es) * | 2002-07-04 | 2005-04-08 | Sanol Arznei Schwarz Gmbh | Utilizacion de carboxamida de heteroareno como ligandos de dopamina-d3 para el tratamiento de enfermedades de cns. |
US7605259B2 (en) * | 2002-09-14 | 2009-10-20 | University Of North Texas Health Science Center At Fort Worth | Structurally rigid dopamine d3 receptor selective ligands and process for making them |
DE10259244A1 (de) * | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | N-(Indolethyl-)cycloamin-Verbindungen |
WO2004082686A2 (en) * | 2003-03-13 | 2004-09-30 | Dynogen Pharmaceuticals, Inc. | Use of compounds with combined 5-ht1a and ssri activities to treat sexual dysfunction |
-
2004
- 2004-12-30 DE DE102004063797A patent/DE102004063797A1/de not_active Ceased
-
2005
- 2005-12-27 CN CNA2005800324230A patent/CN101027294A/zh active Pending
- 2005-12-27 DE DE502005002058T patent/DE502005002058D1/de not_active Expired - Fee Related
- 2005-12-27 CA CA002576332A patent/CA2576332A1/en not_active Abandoned
- 2005-12-27 US US11/794,386 patent/US20080194539A1/en not_active Abandoned
- 2005-12-27 WO PCT/EP2005/014047 patent/WO2006072430A1/de active IP Right Grant
- 2005-12-27 AU AU2005324107A patent/AU2005324107A1/en not_active Abandoned
- 2005-12-27 SI SI200530145T patent/SI1761524T1/sl unknown
- 2005-12-27 DK DK05823871T patent/DK1761524T3/da active
- 2005-12-27 EP EP05823871A patent/EP1761524B1/de active Active
- 2005-12-27 PT PT05823871T patent/PT1761524E/pt unknown
- 2005-12-27 KR KR1020077014615A patent/KR20070102673A/ko not_active Application Discontinuation
- 2005-12-27 PL PL05823871T patent/PL1761524T3/pl unknown
- 2005-12-27 MX MX2007006369A patent/MX2007006369A/es not_active Application Discontinuation
- 2005-12-27 BR BRPI0519485-7A patent/BRPI0519485A2/pt not_active Application Discontinuation
- 2005-12-27 EA EA200701366A patent/EA200701366A1/ru unknown
- 2005-12-27 ES ES05823871T patent/ES2297767T3/es active Active
- 2005-12-27 JP JP2007548748A patent/JP2008526700A/ja active Pending
-
2007
- 2007-01-17 IL IL180763A patent/IL180763A0/en unknown
- 2007-01-18 ZA ZA200701972A patent/ZA200701972B/en unknown
- 2007-05-21 NO NO20072587A patent/NO20072587L/no not_active Application Discontinuation
- 2007-06-05 HK HK07105930A patent/HK1100845A1/xx not_active IP Right Cessation
-
2008
- 2008-02-19 HR HR20080075T patent/HRP20080075T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PT1761524E (pt) | 2008-02-21 |
US20080194539A1 (en) | 2008-08-14 |
AU2005324107A1 (en) | 2006-07-13 |
CA2576332A1 (en) | 2006-07-13 |
EA200701366A1 (ru) | 2008-02-28 |
MX2007006369A (es) | 2007-07-11 |
WO2006072430A1 (de) | 2006-07-13 |
ZA200701972B (en) | 2008-04-30 |
CN101027294A (zh) | 2007-08-29 |
HRP20080075T3 (en) | 2008-03-31 |
EP1761524A1 (de) | 2007-03-14 |
JP2008526700A (ja) | 2008-07-24 |
ES2297767T3 (es) | 2008-05-01 |
EP1761524B1 (de) | 2007-11-21 |
AU2005324107A2 (en) | 2006-07-13 |
HK1100845A1 (en) | 2007-09-28 |
DE502005002058D1 (de) | 2008-01-03 |
SI1761524T1 (sl) | 2008-04-30 |
KR20070102673A (ko) | 2007-10-19 |
BRPI0519485A2 (pt) | 2009-02-03 |
PL1761524T3 (pl) | 2008-04-30 |
DE102004063797A1 (de) | 2006-07-13 |
DK1761524T3 (da) | 2008-04-07 |
IL180763A0 (en) | 2007-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1119699A1 (en) | Pyridopyrimidinone inhibitors of pi3kalpha | |
NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
SE0301700D0 (sv) | Novel compounds | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
PL1877390T3 (pl) | Związki benzizoksazolopiperazynowe i sposoby ich stosowania | |
NO20063821L (no) | Kinolinderivater for anvendelse som mykobakterielle inhibitorer | |
ATE504570T1 (de) | Tartratsalz aus isofagomin und verwendungsverfahren dafür | |
CY1109998T1 (el) | Ενδυναμωτες υποδοχεων γλουταμινικου | |
NO20050828L (no) | lndol-3-svovelderivater | |
NO20055977L (no) | Nye benzimidazolderivater | |
NO20054476L (no) | Forbindelser for behandling av smerte | |
EA200800542A1 (ru) | Пиридинаминосульфонилзамещенные бензамиды в качестве ингибиторов цитохрома р450 3а4 (cyp3a4) | |
EA200870360A1 (ru) | Бензимидазолы, обладающие активностью в отношении рецепторов м1, и их применение в медицине | |
NO20092286L (no) | Nitrogenhaldige heterosykliske forbindelser og anvendelse derav | |
CY1109962T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας | |
NO20055741L (no) | Nye kjemiske forbindelser | |
ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
TW200716529A (en) | New compounds II | |
TW200626564A (en) | Carboxylic acid derivative containing thiazole ring and medical use thereof | |
PL376324A1 (en) | Piperazinyl and diazapanyl benzamides and benzthioamides | |
MX2010002938A (es) | Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer. | |
NO20072005L (no) | Nye heterocykliske amider | |
TW200512201A (en) | New heterocyclic amides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |